We provide the tools that facilitate and drive personalized medicine.
Best in Class Diagnostic Tests
Contextual Genomics’ diagnostic tests are best in class clinical grade cancer assays that digitize biologic samples. We develop and distribute reimbursable tests that are designed to be inexpensive, medically necessary, allow for rapid scaling, and facilitate the collection of longitudinal patient data by monitoring tumor and blood. Local optimization and validation of the tests for business and medical reasons occurs within each of our partners facilities.
Best in Class Bioinformatics Analysis
The cornerstone of quality assurance and accuracy is provided by the proprietary autonomous quality control (QUALITY NEXUS™) . QUALITY NEXUS™ permits “best in class” detection of low frequency mutations and achieves this through the use of a large number of thermodynamically balanced sets of proprietary ‘barcodes’, a machine learning approach for SNV calling and a barcode based analysis creating an opportunity to infer molecular diversity indices and distinguish artifacts from true mutations
Designed for Data Integration
Contextual Genomics facilitates the integration of the diagnostic test results using information exchange standards such as json, HL7 and HL7 CDA. Contextual Genomics also employs extensive use of nomenclature standards such as SNOMED CT, ICD-O-3, LOINC and INN to ensure accurate data exchange.
Our Quality Standards
Contextual Genomics holds full accreditation by the College of American Pathologists (CAP), the Diagnostic Accreditation Program of British Columbia (DAP), and the Centres for Medicare and Medicaid Services Clinical Laboratory Improvements Amendments (CLIA).